 interferon alfa doxorubicin treatment advanc cervic cancer interferon alfa doxorubicin synergist effect vitro cell cervic cancer clinic trial interferon alfa doxorubicin patient advanc recurr cervic cancer patient interferon alfa unit squar meter unit squar meter infus period hour doxorubicin period treatment weekli week initi respons evalu week treatment every-other-week schedul patient favor respons stabl diseas bone marrow hepat renal toxic minim fever malais major sourc toxic evalu patient clinic partial respons respond year surviv regimen patient advanc cervic cancer